For each company, the report analyzes:
- Internally developed and acquired in vitro diagnostics.
- Know-how in biotechnology, engineering, electronics and other related fields.
- Proprietary technologies and patent litigations.
The companies analyzed in the report: Abbott, Bayer Diabetes, Beckman Coulter, Becton Dickinson, bioMerieux, Bio-Rad, J&J, Roche, Siemens, and Sysmex.
Contains 92 pages